Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will ...
AbbVie’s model based fair value has been adjusted only slightly, moving from US$248.29 to US$248.86, which keeps the overall ...
AbbVie (NYSE: ABBV), a pharmaceutical leader, has faced some challenges over the past three years. The company is managing some patent cliffs and clinical setbacks that worried investors and dinged ...
AbbVie Inc. (NYSE:ABBV) ranks among the 14 safe stocks to buy now for a starter stock portfolio. On February 24, RBC Capital began coverage of AbbVie Inc. (NYSE:ABBV) with an Outperform rating and a ...
The company's ability to hold off generic competitors long enough to develop a pair of replacement drugs for Humira that are ...
AbbVie (ABBV) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
The latest announcement is out from AbbVie ( (ABBV) ).
Some valuation metrics suggest that AbbVie is a cheap stock. The company's growth prospects through 2030 look attractive. AbbVie is also an excellent dividend stock. 10 stocks we like better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results